Rankings
▼
Calendar
CRDF FY 2014 Earnings — Cardiff Oncology, Inc. Revenue & Financial Results | Market Cap Arena
CRDF
Cardiff Oncology, Inc.
$137M
FY 2014 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$280,000
+8.0% YoY
Gross Profit
$265,000
94.6% margin
Operating Income
-$15M
-5337.5% margin
Net Income
-$14M
-5116.1% margin
EPS (Diluted)
$-54.08
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$13M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$29M
Total Liabilities
$21M
Stockholders' Equity
$8M
Cash & Equivalents
$27M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$280,000
$259,246
+8.0%
Gross Profit
$265,000
-$3M
+108.2%
Operating Income
-$15M
-$11M
-39.8%
Net Income
-$14M
-$12M
-21.3%
← FY 2013
All Quarters
FY 2015 →